All stock lists
Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
Healthcare · Biotechnology
2.13-0.08 (-3.62%)
Insider Score
––Not scored
ZNTL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ZNTL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 9.23 M | 9.14 M | 7.91 M | 10.78 M | 8.45 M | — |
| R&D Expense | 35.16 M | 28.72 M | 29.49 M | 22.95 M | 27.61 M | — |
| Operating Expenses | 44.39 M | 37.85 M | 37.39 M | 33.73 M | 36.06 M | — |
| Operating Income | -44.39 M | -37.85 M | -37.39 M | -33.73 M | -36.06 M | — |
| Pretax Income | -42.15 M | -35.23 M | -34.77 M | -26.69 M | -26.87 M | — |
| Tax Provision | 138.00 K | 120.00 K | 442.00 K | 0.00 | 0.00 | — |
| Net Income | -42.29 M | -35.35 M | -35.22 M | -26.69 M | -26.87 M | — |
| EPS (Basic) | -0.59 | -0.50 | — | -0.37 | -0.37 | -0.67 |
| EPS (Diluted) | -0.59 | -0.50 | — | -0.37 | -0.37 | -0.67 |
| Shares Outstanding | 71.33 M | 70.26 M | — | 72.14 M | 71.99 M | 71.68 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.